Letter from the
Shareholder Committee

With great respect and in honourable memory of Bernard große Broermann, the founder and shareholder of the Asklepios Group, to whom we very sadly had to say farewell in February 2024, we are assuming the role of the Shareholder Committee. It is a special responsibility and at the same time an honour for us to assume this office in the spirit of Bernard große Broermann and to lead the Asklepios Group into the future in line with his vision.

The year 2023 once again brought major challenges. In times like these, we as a company have to take responsibility and take a stand – in our society, within our industry and especially regarding our employees and patients.

Amidst the uncertainties caused by geopolitical tensions, economic challenges and the planned hospital reform, Asklepios remains committed to offering stability and reliability. The well-being of our patients is always our top priority. The Asklepios Group is consistently committed to this. Instead of complex structures and bureaucracy, we are committed to reducing bureaucracy and promoting digitalisation and innovation in the healthcare sector. When we strive for efficiency, our aim is to give our employees more space for their important work with and for our patients.

The Asklepios Group is characterised by a culture of innovation and cooperation based on partnership, underpinned by the philosophy of a family business. As “VisioNears”, we act with clearly defined values that Bernard große Broermann championed throughout his life: medical quality, innovation and social responsibility. Asklepios also stands for sustainable management, stability and strategic vision. With 164 healthcare facilities, a focus on outpatient medicine and the centres of excellence, the Asklepios Group is well positioned to meet the growing demand for high-quality healthcare.

The right specialists are crucial here. The entire healthcare system is suffering from a shortage of specialists. We at Asklepios are resolutely countering this. To this end, the Group provides targeted initial and ongoing training locally as well as recruiting and integrating specialists from abroad in a targeted manner. Only with a sufficient number of highly qualified employees are we able to improve our medical care on a long-term basis and in a sustainable manner.

We would like to express our deepest gratitude to the dedicated employees of the Asklepios Group. It is their tireless commitment as “VisioNears” that keeps the legacy of Bernard große Broermann alive. We would also like to thank the patients who place their trust in the Asklepios Group.

As “VisioNears”, we at Asklepios not only solve the problems of today, but are already thinking about the challenges of tomorrow – supported by a strong management team. The decision to appoint a new management duo at the head of Asklepios is an expression of Bernard große Broermann’s vision for a company in which harmonious and integrated cooperation across the board is a top priority. With the Management Board and the Shareholder Committee working closely together, we will confidently tackle current and future challenges together and continue to work towards a holistically healthy life.

Members of the Shareholder Committee